Mersana Therapeutics Inc (MRSN)
2.33
-0.07
(-2.92%)
USD |
NASDAQ |
May 31, 16:00
2.335
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Shareholders Equity (Quarterly): 27.98M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 27.98M |
December 31, 2023 | 36.90M |
September 30, 2023 | 52.20M |
June 30, 2023 | 89.80M |
March 31, 2023 | 64.29M |
December 31, 2022 | 92.06M |
September 30, 2022 | 90.23M |
June 30, 2022 | 134.03M |
March 31, 2022 | 140.53M |
December 31, 2021 | 121.74M |
September 30, 2021 | 155.55M |
June 30, 2021 | 195.51M |
March 31, 2021 | 197.94M |
December 31, 2020 | 228.09M |
September 30, 2020 | 253.31M |
Date | Value |
---|---|
June 30, 2020 | 273.56M |
March 31, 2020 | 63.09M |
December 31, 2019 | 78.32M |
September 30, 2019 | 93.04M |
June 30, 2019 | 108.51M |
March 31, 2019 | 124.07M |
December 31, 2018 | 8.795M |
September 30, 2018 | 29.85M |
June 30, 2018 | 45.69M |
March 31, 2018 | 56.55M |
December 31, 2017 | 69.99M |
September 30, 2017 | 83.64M |
June 30, 2017 | -71.66M |
March 31, 2017 | 31.14M |
December 31, 2016 | -55.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
27.98M
Minimum
Mar 2024
273.56M
Maximum
Jun 2020
124.83M
Average
100.78M
Median
Shareholders Equity (Quarterly) Benchmarks
Amicus Therapeutics Inc | 130.69M |
Insmed Inc | -464.81M |
Altimmune Inc | 172.94M |
InfuSystems Holdings Inc | 52.28M |
Anavex Life Sciences Corp | 134.96M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 198.37M |
Total Liabilities (Quarterly) | 170.39M |
Debt to Equity Ratio | 0.9043 |
Current Ratio | 3.512 |
Net Debt Paydown Yield | -0.01% |